ARTICLE | Company News
Visible Genetics, Bayer deal
October 21, 2002 7:00 AM UTC
BAYG's Bayer Diagnostics business group (Tarrytown, N.Y.) completed its previously announced acquisition of VGIN for $61.4 million based on 40.9 million shares at $1.50 (see BioCentury, July 29). ...